Detection of haptenated proteins in organotypic human skin explant cultures exposed to dapsone.
Bioactivation of parent drug to reactive metabolite(s) followed by protein haptenation has been suggested to be a critical step in the elicitation of cutaneous drug reactions. Although liver is believed to be the primary organ of drug bioactivation quantitatively, other organs including skin may also metabolize drugs. Cultured human epidermal keratinocytes and dermal fibroblasts have been shown to be capable of bioactivating sulfonamides and sulfones, giving rise to haptenated proteins. It is, however, unclear whether metabolic events in these isolated cells reflect bioactivation in vivo. Hence, split-thickness human skin explants were exposed to dapsone (DDS) or its arylhydroxylamine metabolite (dapsone hydroxylamine, D-NOH) and probed for protein haptenation. DDS and D-NOH were applied either epicutaneously or mixed in the medium (to mimic its entry into skin from the systemic circulation). DDS-protein adducts were readily detected in skin explants exposed to either DDS or D-NOH. Adducts were detected mainly in the upper epidermal region in response to epicutaneous application, whereas adducts were formed all over the explants when DDS/D-NOH were mixed in the culture medium. In addition, adducts were visible in HLA-DR+ cells, indicating their presence in the dendritic cell population in the skin. Our results demonstrate the ability of intact human skin to bioactivate DDS leading to protein haptenation.
Roychowdhury
Sanjoy
S
Division of Pharmaceutics, College of Pharmacy, The University of Iowa, Iowa City, Iowa, USA.
Cram
Albert E
AE
Aly
Al
A
Svensson
Craig K
CK
D002851:Chromatography, High Pressure Liquid; D003470:Culture Media; D003622:Dapsone / Q000494:pharmacology*; D003713:Dendritic Cells / Q000187:drug effects / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006241:Haptens / Q000032:analysis*; D006801:Humans; D006898:Hydroxylamines / Q000378:metabolism; D007150:Immunohistochemistry; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism; D009924:Organ Culture Techniques; D012867:Skin / Q000737:chemistry* / Q000166:cytology / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology
D003470:Culture Media; D005493:Folic Acid Antagonists; D006241:Haptens; D006898:Hydroxylamines; D013449:Sulfonamides; D003622:Dapsone